• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

    0.9404 +0.0924 (+10.90%)
    Streaming Delayed Price Updated: 10:03 AM EDT, Apr 24, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 147,762
    Open 0.8650
    Bid (Size) 0.9347 (7)
    Ask (Size) 0.9498 (5)
    Prev. Close 0.8480
    Today's Range 0.8622 - 0.9579
    52wk Range 0.7300 - 11.18
    Shares Outstanding 2,172,309
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
    GeoVax to Host Conference Call at 4:30 PM ET 
    Via TheNewswire.com
    Exposures COVID-19

    Performance

    YTD
    -62.1%
    -62.1%
    1 Month
    -32.8%
    -32.8%
    3 Month
    -55.4%
    -55.4%
    6 Month
    -58.2%
    -58.2%
    1 Year
    -38.9%
    -38.9%

    More News

    Read More
    GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
    Via NewMediaWire
    GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
    Via TheNewswire.com
    GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
    Via NewMediaWire
    Exposures COVID-19
    GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
    Via TheNewswire.com
    Exposures COVID-19
    GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
    Via NewMediaWire
    Exposures COVID-19
    Top stock movements in today's session.
    Via Chartmill
    Tuesday's session: top gainers and losers
    Via Chartmill
    GeoVax to Present at the Emerging Growth Conference on April 16, 2025
    Via NewMediaWire
    Exposures COVID-19
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    The market is filled with gapping stocks in Tuesday's session.
    Via Chartmill
    Crude Oil Moves Lower; Citigroup Posts Upbeat Results
    Via Benzinga
    Exposures Fossil Fuels
    Stay updated with the stocks that are on the move in today's pre-market session.
    Via Chartmill
    Nasdaq Surges 100 Points; Bank of America Earnings Top Views
    Via Benzinga
    GeoVax to Present Clinical Data at Upcoming April Industry Events
    Via NewMediaWire
    Exposures COVID-19
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert
    Via Benzinga
    Topics Government
    Exposures Political
    Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Stay updated with the stocks that are on the move in today's after-hours session.
    Via Chartmill
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
    Via NewMediaWire
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property Product Safety
    GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
    Via TheNewswire.com
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property Product Safety
    GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
    Via NewMediaWire
    GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
    Via TheNewswire.com

    Frequently Asked Questions

    Is GeoVax Labs, Inc. - Common Stock publicly traded?
    Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
    What exchange does GeoVax Labs, Inc. - Common Stock trade on?
    GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
    The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
    What is the current price of GeoVax Labs, Inc. - Common Stock?
    The current price of GeoVax Labs, Inc. - Common Stock is 0.9404
    When was GeoVax Labs, Inc. - Common Stock last traded?
    The last trade of GeoVax Labs, Inc. - Common Stock was at 04/24/25 10:03 AM ET
    What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
    The market capitalization of GeoVax Labs, Inc. - Common Stock is 2.04M
    How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
    GeoVax Labs, Inc. - Common Stock has 2M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.